{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:05Z","timestamp":1786980545400,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Provincial 21st Century Education Foundation","award":["WJK-202403-YKX-1"],"award-info":[{"award-number":["WJK-202403-YKX-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03409-0","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T04:24:47Z","timestamp":1740975887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective analysis of the effectiveness and safety of sulodexide for venous thromboembolism prevention in neurosurgical patients"],"prefix":"10.1007","volume":"48","author":[{"given":"Kaixuan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"3409_CR1","first-page":"103628","volume":"77","author":"P Parmontree","year":"2022","unstructured":"Parmontree P, Ketprathum P, Ladnok T et al (2022) Predictive risk factors for venous thromboembolism in neurosurgical patients: a retrospective analysis single center cohort study. Ann Med Surg (Lond) 77:103628. 2022\/06\/01","journal-title":"Ann Med Surg (Lond)"},{"key":"3409_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","volume":"143","author":"CN Bagot","year":"2008","unstructured":"Bagot CN, Arya R (2008) Virchow and his triad: a question of attribution. Br J Haematol 143:180\u2013190 2008\/09\/12. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07323.x","journal-title":"Br J Haematol"},{"key":"3409_CR3","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s00701-023-05792-3","volume":"165","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Cai H, Vleggeert-Lankamp CLA (2023) Thromboembolic prophylaxis in neurosurgical practice: a systematic review. Acta Neurochir (Wien) 165:3119\u20133135 2023\/10\/05. https:\/\/doi.org\/10.1007\/s00701-023-05792-3","journal-title":"Acta Neurochir (Wien)"},{"key":"3409_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/1076029614532008","volume":"20","author":"LP Cote","year":"2014","unstructured":"Cote LP, Greenberg S, Caprini JA et al (2014) Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry. Clin Appl Thromb Hemost 20:772\u2013778. 2014\/05\/07","journal-title":"Clin Appl Thromb Hemost"},{"key":"3409_CR5","doi-asserted-by":"publisher","unstructured":"Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133:381S\u2013453S. https:\/\/doi.org\/10.1378\/chest.08-0656. 2008\/07\/24","DOI":"10.1378\/chest.08-0656"},{"key":"3409_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12028-015-0221-y","volume":"24","author":"P Nyquist","year":"2016","unstructured":"Nyquist P, Bautista C, Jichici D et al (2016) Prophylaxis of venous thrombosis in Neurocritical Care patients: an evidence-based Guideline: A Statement for Healthcare professionals from the Neurocritical Care Society. Neurocrit Care 24:47\u201360. 2015\/12\/10","journal-title":"Neurocrit Care"},{"key":"3409_CR7","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","volume":"363","author":"MR Lassen","year":"2010","unstructured":"Lassen MR, Gallus A, Raskob GE et al (2010) Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med 363:2487\u20132498. 2010\/12\/24","journal-title":"N Engl J Med"},{"key":"3409_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0049-3848(03)00246-9","volume":"109","author":"B Cosmi","year":"2003","unstructured":"Cosmi B, Cini M, Legnani C et al (2003) Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans. Thromb Res 109:333\u2013339. 2003\/06\/24","journal-title":"Thromb Res"},{"key":"3409_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1076029609338711","volume":"15","author":"C Adiguzel","year":"2009","unstructured":"Adiguzel C, Iqbal O, Hoppensteadt D et al (2009) Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide. Clin Appl Thromb Hemost 15:501\u2013511. 2009\/08\/26","journal-title":"Clin Appl Thromb Hemost"},{"key":"3409_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0049-3848(84)90108-7","volume":"34","author":"G Andriuoli","year":"1984","unstructured":"Andriuoli G, Mastacchi R, Barbanti M (1984) Antithrombotic activity of a glycosaminoglycan (sulodexide) in rats. Thromb Res 34:81\u201386 1984\/04\/01. https:\/\/doi.org\/10.1016\/0049-3848(84)90108-7","journal-title":"Thromb Res"},{"key":"3409_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF02591420","volume":"22","author":"M Barbanti","year":"1992","unstructured":"Barbanti M, Guizzardi S, Calanni F et al (1992) Antithrombotic and thrombolytic activity of sulodexide in rats. Int J Clin Lab Res 22:179\u2013184 1992\/01\/01. https:\/\/doi.org\/10.1007\/BF02591420","journal-title":"Int J Clin Lab Res"},{"key":"3409_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2165\/00044011-199510030-00005","volume":"10","author":"GL Messa","year":"1995","unstructured":"Messa GL, La Placa G, Puccetti L et al (1995) Pharmacodynamic effects of Sulodexide on Profibrinolytic and Haemorrheological patterns. Clin Drug Investig 10:165\u2013171 1995\/09\/01. https:\/\/doi.org\/10.2165\/00044011-199510030-00005","journal-title":"Clin Drug Investig"},{"key":"3409_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3389\/fphar.2018.00876","volume":"9","author":"QJ Jiang","year":"2018","unstructured":"Jiang QJ, Bai J, Jin J et al (2018) Sulodexide for secondary Prevention of recurrent venous thromboembolism: a systematic review and Meta-analysis. Front Pharmacol 9:876. 2018\/08\/24","journal-title":"Front Pharmacol"},{"key":"3409_CR14","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.115.016930","volume":"132","author":"GM Andreozzi","year":"2015","unstructured":"Andreozzi GM, Bignamini AA, Davi G et al (2015) Sulodexide for the Prevention of recurrent venous thromboembolism: the Sulodexide in secondary Prevention of recurrent deep vein thrombosis (SURVET) study: a Multicenter, Randomized, Double-Blind, placebo-controlled trial. Circulation 132:1891\u20131897 2015\/09\/27. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016930","journal-title":"Circulation"},{"key":"3409_CR15","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1055\/s-0040-1709731","volume":"4","author":"G Pompilio","year":"2020","unstructured":"Pompilio G, Integlia D, Raffetto J et al (2020) Comparative efficacy and safety of Sulodexide and other extended anticoagulation treatments for Prevention of recurrent venous thromboembolism: a bayesian network Meta-analysis. TH Open 4:e80\u2013e93. 2020\/05\/02","journal-title":"TH Open"},{"key":"3409_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0040-1716874","volume":"46","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Chatterjee S, Kirtane AJ et al (2020) Sulodexide versus Control and the risk of thrombotic and hemorrhagic events: Meta-Analysis of Randomized trials. Semin Thromb Hemost 46:908\u2013918. 2020\/10\/22","journal-title":"Semin Thromb Hemost"},{"key":"3409_CR17","doi-asserted-by":"publisher","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e227S\u2013e277. 2012\/02\/15","journal-title":"Chest"},{"key":"3409_CR18","doi-asserted-by":"publisher","unstructured":"Akrivou D, Perlepe G, Kirgou P et al (2022) Pathophysiological aspects of aging in venous thromboembolism: an update. Medicina 58. https:\/\/doi.org\/10.3390\/medicina58081078","DOI":"10.3390\/medicina58081078"},{"key":"3409_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.diabres.2015.10.019","volume":"111","author":"EJ Bell","year":"2016","unstructured":"Bell EJ, Folsom AR, Lutsey PL et al (2016) Diabetes mellitus and venous thromboembolism: a systematic review and meta-analysis. Diabetes Res Clin Pract 111:10\u201318 2015\/11\/28. https:\/\/doi.org\/10.1016\/j.diabres.2015.10.019","journal-title":"Diabetes Res Clin Pract"},{"key":"3409_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1726-4901(09)70339-9","volume":"70","author":"CC Yang","year":"2007","unstructured":"Yang CC, Kao CC (2007) Cardiovascular diseases and the risk of venous thromboembolism: a hospital-based case-control study. J Chin Med Assoc 70:103\u2013109 2007\/03\/29. https:\/\/doi.org\/10.1016\/s1726-4901(09)70339-9","journal-title":"J Chin Med Assoc"},{"key":"3409_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-2007-1001916","volume":"20","author":"E Marchi","year":"1994","unstructured":"Marchi E, Barbanti M, Milani R et al (1994) Organ glycosaminoglycan distribution after intravenous and oral administration in rats. Semin Thromb Hemost 20:297\u2013300 1994\/01\/01. https:\/\/doi.org\/10.1055\/s-2007-1001916","journal-title":"Semin Thromb Hemost"},{"key":"3409_CR22","doi-asserted-by":"publisher","first-page":"91350","DOI":"10.18632\/oncotarget.20518","volume":"8","author":"T Li","year":"2017","unstructured":"Li T, Liu X, Zhao Z et al (2017) Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model. Oncotarget 8:91350\u201391361. 2017\/12\/07","journal-title":"Oncotarget"},{"key":"3409_CR23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.5114\/aoms.2019.87504","volume":"16","author":"B Gabryel","year":"2020","unstructured":"Gabryel B, Bontor K, Urbanek T (2020) Sulodexide increases mRNA expression of glutathione-related genes in human umbilical endothelial cells exposed to oxygen-glucose deprivation. Arch Med Sci 16:1444\u20131447. 2019\/08\/27","journal-title":"Arch Med Sci"},{"key":"3409_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/000331979704800907","volume":"48","author":"A Pinto","year":"1997","unstructured":"Pinto A, Corrao S, Galati D et al (1997) Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs. Angiology 48:805\u2013811. 1997\/10\/06","journal-title":"Angiology"},{"key":"3409_CR25","doi-asserted-by":"publisher","unstructured":"Kakkos SK, Gohel M, Baekgaard N et al (eds) (2021) \u2018s Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 61:9\u201382. 2020\/12\/19. https:\/\/doi.org\/10.1016\/j.ejvs.2020.09.023","DOI":"10.1016\/j.ejvs.2020.09.023"},{"key":"3409_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"SV Konstantinides","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543\u2013603. 2019\/09\/11","journal-title":"Eur Heart J"},{"key":"3409_CR27","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1093\/eurheartj\/ehx003","volume":"39","author":"L Mazzolai","year":"2018","unstructured":"Mazzolai L, Aboyans V, Ageno W et al (2018) Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J 39:4208\u20134218 2017\/03\/23. https:\/\/doi.org\/10.1093\/eurheartj\/ehx003","journal-title":"Eur Heart J"},{"key":"3409_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3171\/2021.3.SPINE201981","volume":"36","author":"BM Hauser","year":"2022","unstructured":"Hauser BM, Hoffman SE, Gupta S et al (2022) Association of venous thromboembolism following pediatric traumatic spinal injuries with injury severity and longer hospital stays. J Neurosurg Spine 36:153\u2013159 2021\/09\/18. https:\/\/doi.org\/10.3171\/2021.3.SPINE201981","journal-title":"J Neurosurg Spine"},{"key":"3409_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jss.2016.08.072","volume":"207","author":"JP Meizoso","year":"2017","unstructured":"Meizoso JP, Karcutskie CAt, Ray JJ et al (2017) A simplified stratification system for venous thromboembolism risk in severely injured trauma patients. J Surg Res 207:138\u2013144 2016\/12\/17. https:\/\/doi.org\/10.1016\/j.jss.2016.08.072","journal-title":"J Surg Res"},{"key":"3409_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.artd.2020.12.025","volume":"8","author":"B Salomon","year":"2021","unstructured":"Salomon B, Dasa V, Krause PC et al (2021) Hospital length of Stay is Associated with increased likelihood for venous thromboembolism after total joint arthroplasty. Arthroplast Today 8:254\u2013257 e251. 2021\/06\/08. https:\/\/doi.org\/10.1016\/j.artd.2020.12.025","journal-title":"Arthroplast Today"},{"key":"3409_CR31","doi-asserted-by":"publisher","first-page":"e54501","DOI":"10.1371\/journal.pone.0054501","volume":"8","author":"S Yung","year":"2013","unstructured":"Yung S, Chau MK, Zhang Q et al (2013) Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL\/6 mice with streptozotocin-induced type I diabetic nephropathy. PLoS ONE 8:e54501. 2013\/01\/26","journal-title":"PLoS ONE"},{"key":"3409_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11596-009-0608-0","volume":"29","author":"S Chen","year":"2009","unstructured":"Chen S, Fang Z, Zhu Z et al (2009) Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats. J Huazhong Univ Sci Technolog Med Sci 29:715\u2013719. https:\/\/doi.org\/10.1007\/s11596-009-0608-0. 2009\/12\/29","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"3409_CR33","doi-asserted-by":"publisher","unstructured":"Satirapoj B, Kaewput W, Supasyndh O et al (2015) Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial. J Diabetes Res 2015:172038. 2015\/04\/29. https:\/\/doi.org\/10.1155\/2015\/172038","DOI":"10.1155\/2015\/172038"},{"key":"3409_CR34","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/01.ASN.0000014254.87188.E5","volume":"13","author":"G Gambaro","year":"2002","unstructured":"Gambaro G, Kinalska I, Oksa A et al (2002) Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. Randomized trial. J Am Soc Nephrol 13:1615\u20131625. 2002\/06\/01","journal-title":"J Am Soc Nephrol"},{"key":"3409_CR35","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s12325-021-01620-1","volume":"38","author":"AA Bignamini","year":"2021","unstructured":"Bignamini AA, Chebil A, Gambaro G et al (2021) Sulodexide for Diabetic-Induced disabilities: a systematic review and Meta-analysis. Adv Ther 38:1483\u20131513 2021\/01\/28. https:\/\/doi.org\/10.1007\/s12325-021-01620-1","journal-title":"Adv Ther"},{"key":"3409_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1358863X19898253","volume":"25","author":"M Hogan","year":"2020","unstructured":"Hogan M, Berger JS (2020) Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management. Vasc Med 25:160\u2013173 2020\/03\/21. https:\/\/doi.org\/10.1177\/1358863X19898253","journal-title":"Vasc Med"},{"key":"3409_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3171\/2008.3.17480","volume":"110","author":"GH Kim","year":"2009","unstructured":"Kim GH, Hahn DK, Kellner CP et al (2009) The incidence of heparin-induced thrombocytopenia type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin. J Neurosurg 110:50\u201357. 2008\/11\/04","journal-title":"J Neurosurg"},{"key":"3409_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/joneph\/20.3.370","volume":"20","author":"J Borawski","year":"2007","unstructured":"Borawski J, Zbroch E, Rydzewska-Rosolowska A et al (2007) Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II. J Nephrol 20:370\u2013372 2007\/06\/09","journal-title":"J Nephrol"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03409-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03409-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:02:46Z","timestamp":1772118166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03409-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3409"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03409-0","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Date: August 28, 2023\/No:2023\u2009\u2212\u20090635).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}